Cryo-Cell International, Inc. (CCEL) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Cryo-Cell International, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-13.27
Cash-Rich Deficit
P/B Ratio
-1.73
Equity Deficit
Earnings Yield
-7.56%
Yield Gap
Profitability Health
2025Return on Equity
13.06%
Moderate
WeakModerateStrong
Operating Margin
15.34%
Moderate
WeakModerateStrong
Net Profit Margin
-7.70%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-1.31%
Weak
WeakModerateStrong
Net Income Growth
-704.18%
Weak
WeakModerateStrong
EPS Growth
-700.00%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
0.59
Weak
WeakModerateStrong
Quick Ratio
0.57
Weak
WeakModerateStrong
Asset Turnover
0.51x
Moderate
WeakModerateStrong
Inventory Turnover
18.04x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
16.34%
Strong
WeakModerateStrong
EV / Free Cash Flow
8.26x
Strong
WeakModerateStrong
Net Debt / EBITDA
10.24x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
-0.483
Weak
WeakModerateStrong
Return on Invested Capital
10.79%
Weak
WeakModerateStrong
Cash Conversion Cycle
-42.66 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CCEL.
View Financial Statements